Effects of Exercise Combined with Finasteride on Hormone and Ovarian Function in Polycystic Ovary Syndrome Rats
- PMID: 31001337
- PMCID: PMC6436361
- DOI: 10.1155/2019/8405796
Effects of Exercise Combined with Finasteride on Hormone and Ovarian Function in Polycystic Ovary Syndrome Rats
Abstract
Exercise can reduce androgen and insulin levels in polycystic ovary syndrome (PCOS) patients. Finasteride is also presumed to improve the developing follicle environment. Therefore, the aim of this study was to observe the effects of the combination of exercise and finasteride therapy on hormone levels and ovarian morphology in rats with polycystic ovary syndrome. Forty female rats were randomly divided into five groups (n = 8 each group): the PCOS sedentary group (P-Sed), PCOS exercise group (P-Ex), PCOS finasteride and sedentary group (P-FSed), and PCOS finasteride and exercise group (P-FEx), and healthy, age-matched rats were used as controls (CO). The results indicated that the levels of FINS in the P-FEx group were significantly lower than those in the P-Sed and P-FSed groups, while the ratio of fasting blood glucose (FBG)/fasting serum levels of insulin (FINS) in the P-FEx group was significantly higher than that in the P-Sed and P-FSed groups. Compared to the P-FEx group, serum levels of TT (total testosterone) in the P-Sed and P-FSed groups were significantly increased. The thickness of the follicular membrane and the number of atresia follicles in the P-FEx and CO groups were significantly lower than those in the P-Sed group, but there was no significant difference between the P-Ex and P-Sed groups. These results show that the combined usage of exercise and finasteride does not alter the effects of exercise on increasing insulin sensitivity and reducing androgen levels. There is also a synergistic effect of exercise and finasteride on the morphology of the ovary, including a reduced number of atresia follicles and thickness of the follicular membrane.
Figures

Similar articles
-
Exercise training improved insulin sensitivity and ovarian morphology in rats with polycystic ovary syndrome.Horm Metab Res. 2009 Dec;41(12):880-5. doi: 10.1055/s-0029-1234119. Epub 2009 Aug 19. Horm Metab Res. 2009. PMID: 19693748
-
The characterization of obese polycystic ovary syndrome rat model suitable for exercise intervention.PLoS One. 2014 Jun 6;9(6):e99155. doi: 10.1371/journal.pone.0099155. eCollection 2014. PLoS One. 2014. PMID: 24905232 Free PMC article.
-
[Effect of Acupuncture on Reproductive Endocrine and p-Akt Protein Expression in Polycystic Ovary Syndrome Rats with Insulin Resistance].Zhen Ci Yan Jiu. 2018 Oct 25;43(10):622-6. doi: 10.13702/j.1000-0607.170672. Zhen Ci Yan Jiu. 2018. PMID: 30365256 Chinese.
-
Activation of TGF-β1/Smad3 signaling pathway inhibits the development of ovarian follicle in polycystic ovary syndrome by promoting apoptosis of granulosa cells.J Cell Physiol. 2019 Jul;234(7):11976-11985. doi: 10.1002/jcp.27854. Epub 2018 Dec 7. J Cell Physiol. 2019. PMID: 30536903
-
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.Hum Reprod Update. 2014 May-Jun;20(3):334-52. doi: 10.1093/humupd/dmt061. Epub 2013 Dec 16. Hum Reprod Update. 2014. PMID: 24345633
Cited by
-
Shared genes of polycystic ovary syndrome and sedentary behavior as a novel immune landscape biomarker for endometrial cancer.Sci Rep. 2024 Aug 17;14(1):19111. doi: 10.1038/s41598-024-69951-x. Sci Rep. 2024. PMID: 39154063 Free PMC article.
-
Predicting Risk of Insulin Resistance in a Chinese Population with Polycystic Ovary Syndrome: Designing and Testing a New Predictive Nomogram.Biomed Res Int. 2020 Jun 13;2020:8031497. doi: 10.1155/2020/8031497. eCollection 2020. Biomed Res Int. 2020. Retraction in: Biomed Res Int. 2024 Mar 20;2024:9764523. doi: 10.1155/2024/9764523. PMID: 32626764 Free PMC article. Retracted.
References
LinkOut - more resources
Full Text Sources